GSO EN 455-2:2022

EN 455-2:2015
Gulf Standard   Current Edition · Approved on 12 May 2022

Medical gloves for single use - Part 2: Requirements and testing for physical properties

GSO EN 455-2:2022 Files

GSO EN 455-2:2022 Scope

This European Standard specifies requirements and gives test methods for physical properties of single-use medical gloves (i.e. surgical gloves and examination/procedure gloves) in order to ensure that they provide and maintain in use an adequate level of protection from cross contamination for both patient and user. This European Standard does not specify the size of a lot. Attention is drawn to the difficulties that can be associated with the distribution and control of very large lots. The recommended maximum individual lot size for production is 500 000.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners
GSO 2063:2023
 
Gulf Standard
Cosmetic Products - Hair Conditioner (Balsam)
GSO 1223:2023
 
Gulf Standard
Cosmetic Products-Deodorants

Recently Published from Health Sector

GSO ISO 20776-2:2024
ISO 20776-2:2021 
Gulf Standard
Clinical laboratory testing and in vitro diagnostic test systems — Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 2: Evaluation of performance of antimicrobial susceptibility test devices against reference broth micro-dilution
GSO ISO 27186:2024
ISO 27186:2020 
Gulf Standard
Active implantable medical devices — Four-pole connector system for implantable cardiac rhythm management devices — Dimensional and test requirements
GSO ISO 28620:2024
ISO 28620:2020 
Gulf Standard
Medical devices — Non-electrically driven portable infusion devices
GSO ISO 20776-1:2024
ISO 20776-1:2019 
Gulf Standard
Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices — Part 1: Broth micro-dilution reference method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infectious diseases